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Abstract
Hepatocellular carcinoma (HCC) is a leading cause of global cancer mortality. However, little is known about the precise
molecular mechanisms involved in tumor formation and pathogenesis. The primary goal of this study was to elucidate
genome-wide molecular networks involved in development of HCC with multiple etiologies by exploring high quality
microarray data. We undertook a comparative network analysis across 264 human microarray profiles monitoring transcript
changes in healthy liver, liver cirrhosis, and HCC with viral and alcoholic etiologies. Gene co-expression profiling was used to
derive a consensus gene relevance network of HCC progression that consisted of 798 genes and 2,012 links. The HCC
interactome was further confirmed to be phenotype-specific and non-random. Additionally, we confirmed that co-
expressed genes are more likely to share biological function, but not sub-cellular localization. Analysis of individual HCC
genes revealed that they are topologically central in a human protein-protein interaction network. We used quantitative RT-
PCR in a cohort of normal liver tissue (n=8), hepatitis C virus (HCV)-induced chronic liver disease (n=9), and HCC (n=7)to
validate co-expressions of several well-connected genes, namely ASPM, CDKN3, NEK2, RACGAP1, and TOP2A. We show that
HCC is a heterogeneous disorder, underpinned by complex cross talk between immune response, cell cycle, and mRNA
translation pathways. Our work provides a systems-wide resource for deeper understanding of molecular mechanisms in
HCC progression and may be used further to define novel targets for efficient treatment or diagnosis of this disease.
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Introduction
Hepatocellular carcinoma (HCC) is the third most common
cause of cancer-related death worldwide [1]. Annually, more than
620000 new patients are diagnosed with this disease and 1-year
survival rates remain less than 50% [2]. In 70–90% of cases, HCC
develops on a background of chronic liver disease, such as chronic
inflammation or cirrhosis [3]. Worldwide, the main risk factor for
HCC is viral hepatitis, which accounts for 75% of all cases and
results in a 20-fold HCC risk increase in affected patients with
cirrhosis [4]. In the Western world, additional factors such as
alcohol abuse or metabolic disorders (e.g. long-lasting diabetes
mellitus) contribute to increasing incidence rates [5,6]. A precise
molecular understanding of pathological transformations in the
liver remains the key to successful management of this disease.
The advent of high-throughput technologies (e.g. transcript/
protein chips, semi-automated yeast two-hybrid screens) has
allowed simultaneous interrogation of multiple molecular compo-
nents at any given time. Advances in gene expression profiling
have been used to identify key differentially expressed genes and
their pathways in HCC. For example, a high-density cDNA array
was used to correlate overexpression of vimentin (VIM) with
metastatic spread [7]. Additionally, integration of chromosome
aberrations with microarray and proteomic studies has also led to
the development of the first oncogenic HCC database [8]. While
these studies have improved our molecular understanding of
HCC, it is becoming increasingly clear that a single function can
only rarely be attributed to a particular gene or protein [9,10].
Thus, a deeper understanding of multifactorial mechanisms in
HCC progression may be achieved using a systems-wide
approach. This shift in paradigm is attracting substantial interest
and has been applied successfully to define signaling cascades in
cardiac hypertrophy [11], mechanisms of gastric cancer progres-
sion [12], and fundamental organizational properties of metabolic
networks [13]. More recently, integration of HCC gene expression
with topological features of human protein interaction networks
resulted in enhanced diagnosis of HCC [14], while network
analysis of hepatitis C virus (HCV)-induced HCC elucidated
dysfunctional interactions among proteins and aberrant relation-
ships between transcription factors and their target genes [15].
In this study, we expand on the current network-based
interpretation of HCC pathogenesis and undertake a computa-
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key genes and pathways in HCC gene relevance networks derived
from 264 human microarray experiments monitoring normal liver
tissue, liver cirrhosis, and HCC. Our gene co-expression analysis
resulted in a consensus disease network that consisted of 798 genes
and 2012 links. Network clustering approach based on gene co-
expression patterns identified gene clusters involved in immune
response, cell cycle, and mRNA translation pathways. Subsequent
analysis using RT-PCR validated co-expressions of several well-
connected genes localized to the cell cycle cluster, ASPM (asp
[abnormal spindle] homolog, microcephaly associated [Drosoph-
ila]), CDKN3 (cyclin-dependent kinase inhibitor 3), NEK2 (NIMA
[never in mitosis gene a]-related kinase 2), RACGAP1 (Rac
GTPase activating protein 1), and TOP2A (topoisomerase [DNA]
II alpha 170 kDa). Taken together, our results present a resource
for further identification and validation of potential target genes
implicated in HCC pathogenesis.
Results
Inference of gene co-expression networks
We investigated gene expression profiles of normal liver tissue,
hepatitis B/C- (HBV, HCV) and alcohol-induced cirrhosis, and
HCC tumors at various stages of disease and heterogeneous
backgrounds (HCV/HBV, alcohol) (Table 1). To establish
phenotype specificity, we also studied gene expression in breast,
colon, and prostate cancers, as well as normal human tissue,
obtained from the Genome Novartis Foundation’s SymAtlas [16],
which contains 79 different normal human tissues (such as liver,
brain, and heart) and cell types with 2 replicates per tissue/cell
type.
These additional microarray datasets were selected for the
following reasons: 1) breast, colon, and prostate cancers are among
the most common global cancer-related malignancies [17]; 2) due
to the viral or alcoholic etiology and liver-specificity of HCC
tumors, non-liver cancers may be suitable to confirm phenotype-
specificity; 3) all microarray datasets represent highly comprehen-
sive normal and cancerous tissue gene expression profiles that are
available to the scientific community.
For each dataset, genes whose expression correlated above a
predefined Pearson correlation coefficient (PCC) threshold were
represented as nodes in an undirected and unweighted network,
while their co-expressions formed network edges. To select an
appropriate PCC threshold, we compared clustering coefficients of
real and random networks for 0.50#PCC#1.0 [18] (see
Methods, Suppl. Figure S1). Gene co-expression networks
were constructed from HCC datasets (HCC-Net, HCV-Net,
Progression-Net), cancer datasets (Breast-Net, Colon-Net, Pros-
tate-Net), and normal human tissue (Normal-Net) (see Methods,
Table 2). Although, a high confidence normal tissue gene co-
expression network already exists [19], we did not use it for
comparison to tumor networks to preserve consistency in network
reconstruction for all datasets. On average, all networks had large
clustering coefficients than what was expected by chance (Suppl.
Figure S1, mean=0.45, standard deviation=0.06), network
diameters (mean=15, standard deviation=2.9), and assortativities
(mean=0.24, standard deviation=0.05) (Table 2).
Since it is likely that inter- and intra-cellular connectivity
patterns of genes and their products may yield distinct phenotypes
[20,21], we investigated whether phenotypes associated with each
gene co-expression network may be distinguished through their
respective node degree distributions. To test this hypothesis, node
degrees of 762 genes that were common to all gene co-expression
networks (HCC-Net, HCV-Net, Progression-Net, Breast-Net,
Colon-Net, Prostate-Net, Normal-Net) were projected onto two
principal components (PCs). This analysis demonstrated that the
HCC interactomes clustered together and were clearly separated
from other cancers as well as the normal human interactome, in
terms of their node connectivity properties, suggesting phenotype-
specificity captured by distinct co-expression patterns (Figure 1A).
Conserved co-expression network in hepatocellular
carcinoma
It was previously established that the conservation of gene co-
expressions across multiple microarray experiments would im-
prove reliability of network inference [12]. Thus, recurrence of a
co-expression link in all three HCC networks was evaluated. The
HCC-Net and HCV-Net shared 1164 genes and 3184 links, the
HCC-Net and Progression-Net shared 1808 genes and 7221 links,
and the HCV-Net and Progression-Net shared 2507 genes and
10411 links (Figure 1B). There were 798 genes and 2012 links
that were common to all three networks – termed the ‘‘Conserved-
Net’’ hereafter (Figure 1B, Suppl. Table S1, Suppl. Table
S2).
To test if the node degree distribution of the Conserved-Net
follows a power-law, p(x),x
2alpha, we applied maximum-likelihood
fitting methods with goodness-of-fit tests based on the Kolmo-
gorov-Smirnov statistic and likelihood ratios, described previously
[22]. The alpha value of the power-law fit was estimated to be 1.67,
while the lower cut-off, xmin, for the scaling region was 1. The p-
Table 1. Summary of microarray datasets.
Microarray
Dataset Name Experimental Conditions Platform
Number of
Probes
Number of Probes
after preprocessing
ArrayExpress
Accession Number
HCC Dataset [82] Normal Liver, HBV/HCV/Alcoholic Cirrhosis,
HCC N=65
HG-U133A 22283 13149 E-TABM-36
HCV Dataset [66] Normal Liver, HCV-HCC N=124 HG-U133A_2 22277 13149 E-GEOD-14323
Progression Dataset [44] Normal Liver, HCV-Cirrhosis, 4 stages of HCV-
HCC N=75
HG-U133A Plus 2 54675 21358 E-GEOD-6764
Breast Dataset [68] Normal, breast tumor N=86 HG-U133A 22283 13149 E-GEOD-15852
Colon Dataset [69] Normal, colon cancer N=47 HG-U133A 22283 13149 E-MTAB-57
Prostate Dataset [70] Normal, prostate cancer N=154 HG-U133 Plus 2 54675 21359 E-GEOD-17951
Normal Dataset [16] Normal tissue and cell lines N=158 HG-U133A 22283 13149 E-TABM-145
HCC=Hepatocellular Carcinoma; HBV=Hepatitis B Virus, HCV=Hepatitis C Virus.
doi:10.1371/journal.pone.0035510.t001
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distributions and the power-law was calculated using the approach
described in [22]. If the resulting p-value is greater than 0.1, the
power-law is a plausible hypothesis for the data, otherwise it is
rejected. For the Conserved-Net, the p-value for the power-law fit
was 0. Thus, there is a no support for the power-law node degree
distribution in the Conserved-Net (Figure 1C).
To ensure that the Conserved-Net intersections are statistically
significant, we randomized the HCV-Net, HCC-Net, and
Progression-Net by shuffling the edges of each network 538940,
83900, and 2197996 times respectively, while preserving the
original node degrees of all nodes (Maslov-Sneppen [MS] model
[23]). This procedure was repeated 200 times (see Methods),
while calculating the number of common genes and links between
the randomized networks for all iterations. On average, intersec-
tions of randomized HCC networks contained 7.9 genes (standard
deviation=3.9) and 4.1 links (standard deviation=2.1). Thus,
identification of 798 genes and 2012 links in the Conserved-Net
was significantly non-random (z-score=198, Figure 1D).
Next, the coverage of Conserved-Net, in terms of the number of
oncogenes present, was estimated by searching for genes with
known somatic mutations implicated in carcinogenesis. We used
Table 2. Measures of graph structure and topology across various tumor and normal networks.
Network
PCC
cutoff Nodes Edges
Average
degree
Clustering
coefficient Diameter
Fraction of nodes
in giant
component Assortativity
HCC-Net 0.76 3155 20975 13.1 0.38 19 0.78 0.31
HCV-Net 0.73 6661 134735 40.5 0.44 16 0.96 0.15
Progression-Net 0.65 13801 549499 79.6 0.40 14 0.98 0.23
Breast-Net 0.66 8918 351819 78.9 0.44 12 0.99 0.25
Colon-Net 0.75 7889 265520 67.3 0.41 15 0.98 0.20
Prostate-Net 0.59 16955 2703937 318.9 0.54 11 0.99 0.23
Normal-Net 0.77 5483 114126 41.6 0.52 18 0.93 0.28
Conserved-Net NA 798 2012 5.0 0.32 10 0.28 0.49
HCC=Hepatocellular Carcinoma; HBV=Hepatitis B Virus, HCV=Hepatitis C Virus, PCC=Pearson correlation coefficient.
doi:10.1371/journal.pone.0035510.t002
Figure 1. Properties of gene co-expression networks. A) Principal component analysis (PCA) of connectivity patterns in HCC datasets and
breast, colon, and prostate cancers as well as the normal human tissue. B) Venn diagram of conserved genes and links in three HCC datasets with
different etiologies. C) The cumulative distribution function P(x) and the maximum likelihood power-law fit for the node degree distribution in the
Conserved-Net. The alpha parameter represents the scaling exponent in the power-law fit, p(x),x
2alpha, while xmin represents the lower cut-off for
the scaling region. The corresponding p and goodness-of-fit (g.o.f.) values were computed according to the method described in [22]. The red line
represents visualization of a power-law distribution of the form p(x),x
2alpha for x$xmin. D) Comparison of Conserved-Net to intersections of
randomly generated networks.
doi:10.1371/journal.pone.0035510.g001
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reference and determined that of the 798 genes in the Conserved-
Net, 410 (51%) had documented roles in tumorigenesis.
Topological properties of the Conserved-Net
To evaluate topological organization of the Conserved-Net
further, we assessed network betweenness, clustering coefficients,
assortativity, diameter, and modularity. These parameters were
also measured in 200 random networks obtained using the MS
model (see Methods). Real node degrees and network diameters
were not significantly different from random networks. This was
expected since the MS algorithm preserves original node degree
distribution of the original network. Nevertheless, betweenness,
clustering coefficients, assortativity, and modularity of the
Conserved-Net were significantly different to those observed in
random models (Figure 2 A–E).
Interestingly, the Conserved-Net was characterized by a
substantially smaller average node degree compared to individual
HCC networks (Conserved-Net [average degree=5.0] vs. HCC-
Net [average degree=13.1], HCV-Net [average degree=40.5],
Progression-Net [average degree=79.6], Table 2), which may
indicate a greater degree of fragmentation in the consensus
network. Network fragmentation was previously assessed by
calculating the fraction of nodes that belong to the largest
connected component of a network [25,26]. Smaller connected
components indicate more fragmented networks. The fraction of
nodes that formed the largest connected component of the
Conserved-Net was 0.28, compared to 0.78, 0.96, and 0.98 for
HCV-Net, HCC-Net, and Progression-Net respectively (Table 2),
supporting the notion that the Conserved-Net is fragmented.
Given that biologically essential genes may encode proteins that
localize centrally in a protein-protein interaction network (PPIN)
[27], we mapped 798 Conserved-Net genes (HCC genes) onto a
high-confidence human PPIN (see Methods) consisting of 57228
interactions among 11203 proteins. We then calculated node
degrees, betweenness centralities, and clustering coefficients of 468
(59%) genes that could be mapped into the PPIN. All topological
values of mapped HCC genes were significantly larger than
remaining genes in the PPIN (Figure 3A–C), while cyclin-
dependent kinase 1 (CDKN1) was the only hub node in both the
Conserved-Net (node degree=26) and network of PPIs (node
degree=86). Of note, while 468 HCC genes could be mapped to
the PPIN, 216 (46%) of these contained 446 direct protein-protein
interactions and could be enriched for GO-Fat terms ‘Transla-
tion’, ‘Wound healing’, ‘Immune response’, ‘Cell cycle’, and
‘Negative regulation of apoptosis’.
Biological interpretation of the Conserved-Net
To provide insight into molecular pathways that are reflected by
the 798 genes in the Conserved-Net, we used the DAVID
functional enrichment tool to identify over-represented Biocarta,
KEGG, and Reactome pathways (see Methods). The most
abundant pathways were Reactome pathways that include ‘Cell
Cycle, Mitotic’ (n=37 genes, p=1.38610
24), ‘Metabolism of
proteins’ (n=36 genes, p=1.36610
27), and ‘Signaling in Immune
system’ (n=30 genes, p=0.0072) (Table 3). Other pathways
largely represented genes involved in immune response, transla-
tion, and remodeling of the extracellular matrix.
An important characteristic of most biological networks is that
they tend to naturally organize into modules [28]. We tested
whether genes that localized to the same module in the
Conserved-Net share biological function. We calculated the
number of common functional terms (GO-BP, GO-CC, Reactome
pathways) between co-expressed genes in clusters identified by
either MCL or Louvain clustering algorithms and compared them
to randomly generated clusters with identical number of genes and
links. Two independent clustering algorithms were chosen to
ensure validity of our observations and functional similarity
between all genes was expressed using the Jaccard coefficient
(see Methods).
The MCL algorithm partitioned the Conserved-Net into 247
clusters (modularity=0.53). The largest cluster contained 30
Figure 2. Topological properties of the Conserved-Net. Average betweennes, clustering coefficient, as well as assortativity, diameter, and
modularity of the Conserved-Net compared to 200 Markov-Sneppen (MS) random graphs (A–E). Real node degrees were not significantly different
from random networks. Betweenness centrality, clustering coefficients, assortativity, and modularity of the Conserved-Net were significantly different
to those observed in random models (z-scores=40.5, 98.9, 22.9, 75.5, respectively).
doi:10.1371/journal.pone.0035510.g002
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network. A–C) Average node degree, betweenness centrality, and clustering coefficient of HCC-associated genes derived from the Conserved-Net
compared to other genes in the human PPIN. Error bars indicate standard error of the mean (SEM). Statistical significance was calculated using
Wilcoxon rank sum test.
doi:10.1371/journal.pone.0035510.g003
Table 3. Functional enrichment of the 798 genes in the Conserved-Net for Reactome, KEGG, and Biocarta pathways.
Category Term Count P-value Benjamini
Reactome Pathway REACT_152:Cell Cycle, Mitotic 37 1.38610
24 0.0027
Reactome Pathway REACT_17015:Metabolism of proteins 36 1.36610
27 8.04610
26
Reactome Pathway REACT_6900:Signaling in Immune system 30 0.0072 0.082
Reactome Pathway REACT_1762:39 -UTR-mediated translational regulation 23 6.55610
27 1.93610
25
Reactome Pathway REACT_6167:Influenza Infection 23 3.10610
24 0.0046
KEGG Pathway hsa04060:Cytokine-cytokine receptor interaction 22 0.020 0.33
KEGG Pathway hsa03010:Ribosome 21 4.86610
29 6.91E
27
KEGG Pathway hsa04062:Chemokine signaling pathway 19 0.0051 0.11
KEGG Pathway hsa04510:Focal adhesion 18 0.022 0.32
KEGG Pathway hsa05322:Systemic lupus erythematosus 17 2.40610
25 0.0011
KEGG Pathway hsa04110:Cell cycle 17 4.12610
24 0.012
KEGG Pathway hsa04610:Complement and coagulation cascades 16 9.46610
27 6.72610
25
KEGG Pathway hsa04512:ECM-receptor interaction 15 5.51610
25 0.0020
Reactome Pathway REACT_1538:Cell Cycle Checkpoints 15 0.011 0.10
Reactome Pathway REACT_13552:Integrin cell surface interactions 11 0.032 0.21
Reactome Pathway REACT_16888:Signaling by PDGF 10 0.019 0.15
KEGG Pathway hsa04540:Gap junction 10 0.032 0.34
KEGG Pathway hsa05130:Pathogenic Escherichia coli infection 8 0.022 0.29
KEGG Pathway hsa04672:Intestinal immune network for IgA production 7 0.0332 0.33
BIOCARTA h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules 6 4.10610
24 0.057
KEGG Pathway hsa05020:Prion diseases 6 0.028 0.33
BIOCARTA h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway 5 0.0030 0.19
BIOCARTA h_thelperPathway:T Helper Cell Surface Molecules 5 0.0043 0.18
BIOCARTA h_amiPathway:Acute Myocardial Infarction 5 0.0059 0.19
BIOCARTA h_stathminPathway:Stathmin and breast cancer resistance to
antimicrotubule agents
5 0.0059 0.19
BIOCARTA h_Ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in
Macrophage
5 0.0079 0.21
BIOCARTA h_LairPathway:Cells and Molecules involved in local acute
inflammatory response
5 0.013 0.27
BIOCARTA h_fibrinolysisPathway:Fibrinolysis Pathway 4 0.025 0.40
BIOCARTA h_classicPathway:Classical Complement Pathway 4 0.032 0.44
Terms are sorted by the number of representative genes (Count). Enrichment p-values (P-value) which were then adjusted using Benjamini-Hochberg multiple testing
correction.
doi:10.1371/journal.pone.0035510.t003
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Louvain algorithm partitioned the Conserved-Net into 139
clusters (modularity=0.85) with 89 and 2 genes in the largest
and smallest clusters respectively. Both clustering algorithms
produced high functional similarity values for GO-BP (12.3 times
greater Jaccard coefficient [MCL vs. Random], 10.9 times greater
Jaccard coefficient [Louvain vs. Random]) and Reactome (18.2
times greater Jaccard coefficient [MCL vs. Random], 7.7 times
greater Jaccard coefficient [Louvain vs. Random]) terms
(Figure 4A) compared to respective random partitions. Interest-
ingly, GO-CC similarities were not substantially higher in real
modules compared to random (2.3 times greater Jaccard
coefficient [MCL vs. Random], 2.4 times greater Jaccard
Coefficient [Louvain vs. Random]).
Next, due to high functional similarities within partitions,
parameter-independent clustering results, and high modularity of
identified clusters we selected results produced by the Louvain
algorithm for further functional exploration of the Conserved-Net
(Figure 4B). Enrichment for over-represented GO-BP terms in
gene clusters with .10 genes, revealed presence of processes
involving ‘Cell cycle’ (p=6.80610
229, Cluster 5), ‘Translation
elongation’ (p=2.10610
216, Cluster 3), and ‘Extracellular matrix
organization’ (p=1.23610
29, Cluster 1) processes (Table 4).
Contribution of the normal liver to the Conserved-Net
It was of interest to investigate to what extent gene co-
expression modules in the Conserved-Net were contributed by the
normal liver tissue. Results may reveal conserved gene clusters that
could represent important oncogenic pathways.
To identify conserved gene modules, we repeated gene co-
expression analysis of the HCC datasets in the absence of the
normal liver profiles. Co-expression networks were constructed by
selecting the appropriate PCC cutoff (Suppl. Figure S2), as
described in the previous sections, and retaining genes and co-
expressions conserved in all three HCC microarray datasets. The
resulting consensus network of gene co-expressions in malignant
samples (tConserved-Net) contained 499 genes and 1256 links. Of
these, 377 genes (47%) and 792 links (40%) were shared with the
Conserved-Net, while 300 genes and 464 links were specific only
to the tConserved-Net (Figure 5A). Overall, 407/499 (82%) genes
of tConserved-Net were also present in the Conserved-Net, while
92/499 (18%) were specific to the tConserved-Net.
The Louvain algorithm partitioned the tConserved-Net into 96
clusters (modularity=0.79), with the largest cluster containing 66
genes. Subsequently, we used the Jaccard coefficient to measure
the overlap between gene sets assigned to either Conserved-Net or
tConserved-Net clusters (Figure 5B). Among the cluster with
more than 10 genes, clusters 5 (‘Cell cycle’, Jaccard coeffi-
cient=0.72), 6 (‘Immune response’, Jaccard coefficient=0.93),
and 8 (‘Cell surface receptor linked signal transduction’, Jaccard
coefficient=0.50) of the Conserved-Net were preserved the most
in the tConserved-Net. Conversely, clusters 4 (‘Regulation of
transcription, DNA-dependent’), 7 (‘Sensory perception of smell’),
9 (‘Metabolic process’), and 11 (‘Antigen processing and
presentation of peptide antigen via MHC class I’) were eliminated
in the tConserved-Net.
RT-PCR validation
Following the computational analyses of HCC-relevant gene
network topologies, we used quantitative RT-PCR in a cohort of
normal liver tissue (elevated transaminases but without underlying
liver disease or structural changes of the tissue, n=8), HCV-
induced chronic liver disease (n=9), and HCC (n=7) to identify
transcripts and validate co-expressions of five well-connected
genes, namely ASPM (node degree=6), CDKN3 (node de-
gree=21), NEK2 (node degree=14), RACGAP1 (node de-
gree=11), and TOP2A (node degree=31) in the ‘Cell cycle’
cluster of Conserved-Net.
At the transcript expression level, statistical significance was
noted for RACGAP1, NEK2, and TOP2A (Figure 6A). RAC-
GAP1 transcript levels were elevated only slightly (p=0.059) in
HCC tissue compared with normal liver, whereas the difference
was significant (p=0.046) in fibrotic tissue compared to normal
liver. NEK2 expression levels were significantly elevated in fibrotic
tissue of Hepatitis C patients compared to both normal controls
(p=0.002) and HCC (p,0.001). Finally, TOP2A was significantly
upregulated in HCC compared to normal liver (p=0.05).
Figure 4. Functional enrichment of the Conserved-Net. A) Jaccard functional similarity coefficient between co-expressed greater in MCL and
Louvain partitions compared to random partitions with identical numbers of nodes and edges. B) Visualization of the Conserved-Net where each
node corresponds to a gene and links correspond to conserved co-expressions. Node colors illustrate cluster assignments produced by the Louvain
algorithm and node sizes are proportional to node degree.
doi:10.1371/journal.pone.0035510.g004
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confirmation of links in the Conserved-Net was achieved for all
genes with the exception of NEK2 and RACGAP1 (Figure 6B,
6C). The highest PCCs were observed between ASPM and
TOP2A (PCC=0.86, p=1.4610
28) and CDKN3 and TOP2A
(PCC=0.68, p,0.001). Unexpected correlation was noted
between NEK2 and RACGAP1 (PCC=0.57, p=0.004). Overall,
although some transcript expression differences between normal
and HCV/HCC tissues were not statistically significant, presence
of 3/6 co-expressions and absence of 3/3 co-expressions were
validated by RT-PCR. As such our study offers a preliminary
resource for potential gene regulatory patterns that may be
validated further in larger patient cohorts.
Discussion
This study provides an overview of the structure and function of
gene co-expression networks across relevant microarray experi-
ments monitoring gene expression in normal liver, liver cirrhosis,
and HCC. The primary goal of this work was to describe network
topology and identify genome-wide biological mechanisms asso-
ciated with pathogenesis of HCC. Importantly, results of our work
offer a phenotype-specific genomic resource that may be used for
further validation in a laboratory setting.
Since threshold selection is a critical aspect in network inference
studies, we systematically compared topology of real and random
networks to identify an appropriate cut off [18]. This approach is
particularly useful when multiple microarray experiments were
carried out on different platforms. At each PCC threshold, all
microarray networks exhibited a high (0.45) clustering coefficient,
a typical characteristic of structured graphs, that is also consistent
with general behavior of biological networks [29] and topologies
detected in protein-protein interaction collections such as
STRING [30] and IntAct [31].
Using principal component analysis (PCA), we confirm that
connectivity patterns of all HCC networks are phenotype-specific
and differ substantially from breast, colon, and prostate cancers as
well as the normal human interactome (Figure 1A). This
Table 4. Functional enrichment of clusters with at least 10 genes for over-represented Gene Ontology (GO)-Biological Process (BP)
terms.
GO-BP terms Cluster P-value
Extracellular matrix organization 1 1.23610
29
Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II 2 1.85610
28
Translational elongation 3 2.10610
216
Regulation of transcription, DNA-dependent 4 1.68610
23
Cell cycle 5 6.80610
229
Immune response 6 2.45610
23
Sensory perception of smell 7 2.21610
23
Cell surface receptor linked signal transduction 8 3.00610
25
Metabolic process 9 2.95610
23
Transcription initiation from RNA polymerase II promoter 10 8.70610
24
Antigen processing and presentation of peptide antigen via MHC class I 11 1.53610
29
doi:10.1371/journal.pone.0035510.t004
Figure 5. Comparison of Conserved-Net with consensus co-expression network generated by exclusion on normal liver tissue from
HCC datasets (tConserved-Net). A) Venn diagram visualizing intersection and differences of Conserved-Net and t-Conserved-Net. B) Bar graph of
Jaccard coefficients that reflect the overlap between gene sets assigned to either Conserved-Net or tConserved-Net clusters by the Louvain
algorithm. Only gene clusters with more than 10 genes were used in the analysis. Higher Jaccard coefficient value is indicative of a greater
conservation of a cluster between Conserved-Net and tConserved-Net. Red arrows indicate gene clusters that were lost in the absence of normal liver
tissue.
doi:10.1371/journal.pone.0035510.g005
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hypothesized to illustrate global topological patterns and differen-
tial gene cross-talk which may be indicative of a unique
phenotype. Fundamentally, this approach is different to evaluation
of gene expression alone, which does not take into account
complex relationships between genes within a biological system.
Previously, phenotype-specificity was established at the gene
expression level [32]. However, such approaches rely on temporal
behavior of a single gene across tissues and do not consider systems
level relationships between genes. We also note that all cancer
networks shared 158 genes and 157 links, suggesting that there
may be a general ‘‘onco-’’ signature that may be explored in future
studies.
Due to the high-throughput nature of microarray technology
and a large number of co-expression links (.700000), it is possible
that some of these links are false positives or features of a specific
microarray platform. Thus, evaluation of conserved co-expression
links across three HCC networks has a number of additional
strengths compared to conventional statistical approaches. First,
we used an automated method for selection of PCC thresholds, as
an objective filtering process to select significant co-expressions
that eliminates the necessity to apply a stringent statistical cut off,
such as a p-value or a fold change [18]. Second, the data was
combined at the level of correlation matrices, rather than gene
expression levels, which facilitates between-study comparisons [33]
and improves functional relevance of co-expressed genes [12].
Finally, reproducible co-expressions are less likely to be false-
positives and may reflect a biologically relevant link [34]. For
example, in a meta-analysis of .300 tissue samples of gastric
cancer, this hypothesis helped to identify a functional link between
prognostic marker PLA2G2A and the EphB2 receptor [12].
Due to a heterogeneous etiology of HCC datasets, conserved
co-expressions provide an overview of common mechanism in
tumors with HCV, HBV, and alcoholic backgrounds. We identify
798 genes and 2012 conserved co-expressions that formed
Conserved-Net. This interactome was confirmed to be non-
random. Interestingly, of the 798 genes in the Conserved-Net, 331
(41%) had known roles in tumorigenesis. In addition, automated
PubMed search for 798 genes in the context of ‘Hepatocellular
Carcinoma’, ‘Cancer’, ‘Hepatitis B’, ‘Hepatitis C’, ‘Alcohol’, or
‘Cirrhosis’ identified that 507/798 (64%) genes had at least one
matching abstract (data not shown), suggesting that the Con-
served-Net provides acceptable coverage of the current molecular
knowledge in HCC and may contain some novel tumor-associated
genes.
Network topology analysis of the Conserved-Net was undertak-
en to characterize importance of individual genes within the
established interactome. Such systems modeling approaches may
be used to define putative drug targets in HCC and improve
efficacy of current therapies [35,36]. First, it was confirmed that
the topological properties (betweeneess, clustering coefficients,
assortativity, diameter, and modularity) of the Conserved-Net are
Figure 6. RT-PCR validation of co-expression links among topologically central genes in the ‘Cell cycle’ cluster of the Conserved-
Net. A) Expression of ASPM, CDKN3, NEK2, RACGAP1, and TOP2A. Illustrated P-values are based on pairwise comparisons by Mann-Whitney U tests, if
global Kruskal-Wallis test revealed significant differences (p,0.05). B) Heatmaps visualizing comparison of average gene co-expressions in HCC
microarray datasets with respective transcript co-expressions assessed using RT-PCR. Numbers on each heatmap represent Pearson Correlation
Coefficients (PCC). Only statistically significant PCCs were reported for RT-PCR transcripts. P,0.05 was considered significant.
doi:10.1371/journal.pone.0035510.g006
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node importance [37].
The Conserved-Net exhibited a small average node degree
compared to individual HCC networks (Table 2), likely reflecting
fragmentation of the network into disconnected components.
Biologically this finding implies that HCC tumors with diverse
etiologies (HCV-/HBV-infection, and alcoholic backgrounds)
monitored by individual microarray datasets contain surprisingly
few shared gene co-expression patterns, suggesting molecular
heterogeneity of each etiology [38].
The consensus HCC network was also highly assortative
(assortativity=0.49), suggesting that genes with similar node
degrees tend to co-express. Additionally, assortativity of the
conserved HCC network was higher compared to individual
HCC networks. These results are unexpected, since previous
studies report that gene co-expression networks are typically
disassortative, i.e. high-degree genes tend to connect to low-degree
genes [37,39]. Recently, increased assortativity was reported to be
associated with highly fragmented networks [40], further support-
ing our observation of fragmentation in the Conserved-Net.
The Conserved-Net was studied at the level of individual genes.
For example, CD53 was the most connected gene (36 co-
expressions) and has been shown to be associated with metastatic
spread in hepatocellular carcinoma [41]. Of interest, ArhGAP15
(Rho GTPase activating protein 15) was noted to be a
‘‘bottleneck’’ gene [27] with the highest betweenness centrality
measure in the Conserved-Net (13551). ArhGAP15 is a member of
the Rho GTPase activating family of proteins, which act to
catalyze the hydrolysis of GTP that is bound to Rho, Rac and/or
Cdc42, thus inactivating regulators of the actin cytoskeleton. This
family of proteins is emerging as a set of attractive tumor
suppressor genes in hepatocellular carcinoma [42,43]. Of note,
there were 6 genes belonging to Rho GTPase family (ArhGAP15,
RHOQ, RAC2, ArhGAP25, ECT2, RACGAP1).
Other topologically important genes were determined to be
CCNB1 (Cyclin B1, node degree=41), AEBP1 (adipocyte
enhancer binding protein 1, node degree=26), and TTK
(Phosphotyrosine picked threonine-protein kinase, node de-
gree=20). CCNB1 has been shown to be upregulated in HCV-
induced HCC [44], while AEBP1 has been demonstrated to
manifest a proinflammatory function by up-regulating NF-kappaB
and suggested as a potential therapeutic target for the treatment of
various chronic inflammatory diseases and cancer [23]. Finally,
TTK is known to be upregulated in anaplastic thyroid carcinoma
[18] and associated with increased risk of breast cancer [23]. Of
interest, Conserved-Net also identified VIM (vimentin, node
degree=11), a well-characterized marker of epithelial–mesenchy-
mal transition [45], which is also known to be a marker of poor
HCC prognosis [46]. Recently, VIM was reported to be
upregulated in response to alcohol in Caco-2 (colon cancer),
MCF-7 and MDA-MB-231 (breast cancer), and IEC-6 (non-
transformed, normal intestinal) cell lines [47] further suggesting
the presence of alcohol etiology in the Conserved-Net.
Potential functional importance of 798 genes in the Conserved-
NET was explored through mapping them onto a high-confidence
human PPIN. Interestingly, for the 468/798 (59%) genes that
could be mapped to the PPIN, node degree, betweenness
centrality, and clustering coefficients were significantly higher
compared to other genes in the human interactome. These
findings are consistent with the general behavior of tumor genes
[29,48] and indicate that genes inferred by co-expression analysis
may indeed be functionally critical due to their central topologies
in the human PPIN [49]. It was also of interest to note that while
468 HCC genes could be traced on the PPIN, 216 (46%) of these
contained 446 direct protein-protein interactions and could be
enriched for GO-Fat terms ‘Translation’, ‘Wound healing’,
‘Immune response’, ‘Cell cycle’, and ‘Negative regulation of
apoptosis’. Our observations indicate that the above processes may
be disrupted at the protein-interaction level and are likely to
contribute to pathogenesis of HCC.
Delineation of the community structure in interactomes is an
important aspect of network biology that may highlight general
signaling mechanisms associated with disease [50]. We explored
gene cluster architecture of the Conserved-NET using MCL and
Louvain clustering algorithms. We confirmed our hypothesis that
genes with similar biological function tend to co-localize to the
same network module. Interestingly, MCL and Louvain algo-
rithms produced comparable functional homogeneity within
respective partitions, suggesting that both methods are useful for
identification of functionally relevant network modules. Of note,
co-expressed genes tended to have higher GO-BP and Reactome
pathways term similarity. This implies that gene co-expression is
more likely to occur between functionally related genes rather that
between genes with similar subcellular localizations.
Due to high functional similarities within partitions and
parameter-independent clustering results, we selected results
produced by the Louvain algorithm for further functional
exploration of the Conserved-Net. Enrichment of 11 modules
(.10 genes each) for GO-BP terms, demonstrated that HCC is a
heterogeneous disease that relates to processes such as ‘Cell cycle’,
‘Translation elongation’, and ‘Extracellular matrix organization’.
Previously, protein levels and kinase activities of cyclin D1, E,
Cdk4, cyclin A, and Wee1 were demonstrated to increase
proportionally with the development of HCC, especially in the
transition process from chronic hepatitis to HCC [51]. Addition-
ally, 6 genes involved in cell-cycle control and proliferation (BIC,
CPNE1, RBPMS, RFC4, RPSA, TOP2A) were among the most
significantly upregulated genes both in dedifferentiated HCC and
in HCC with loss of chromosomal region 13q [52]. Interestingly,
RFC4 (node degree=1) and TOP2A (node degree=31) were
identified in the Conserved-Net and localized to the ‘Cell cycle’
enriched cluster. These results suggest that gene topological
properties may be explored further in a laboratory setting.
Previous studies suggest that premalignant transformations in
extracellular composition play a key role in pathogenesis of HCC
[53]. We support this hypothesis through identifying a cluster of 89
genes and 318 co-expressions enriched for ‘Extracellular matrix
organization’. Among these, we identified several proteins
associated with extracellular remodeling (MMP2 and ADAMTS1),
which were also previously implicated in HCC progression
[54,55]. Finally, identification of genes involved in ‘Translational
elongation’, suggests that the mRNA translation program is
activated in HCC. Indeed, this is consistent with the long-standing
understanding that coordination and specific activation of
translation factor genes might be involved in the process of liver
carcinogenesis [56]. Thus, gene enrichment reflects the biology of
HCC.
To investigate the extent to which gene co-expression clusters in
the Conserved-Net were contributed by the normal liver tissue, we
have repeated network inference using the HCC microarray
datasets in the absence of normal liver tissue. Our findings indicate
that 407/499 (82%) genes in the tConserved-Net were also present
in the Conserved-Net. These conserved genes represented clusters
enriched for ‘Cell cycle’, ‘Immune response’, and ‘Cell surface
receptor linked signal transduction’, reiterating the importance of
these biological processes in the development of HCC [57].
Surprisingly, only 92/499 (18%) genes were specific to the
tConserved-Net, suggesting that only a small fraction of genes is
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are specific to the Conserved-Net were likely contributed by the
inclusion of normal liver in the computational analysis.
To experimentally validate co-expressed genes that belong to
the ‘Cell cycle’ cluster, we measured transcript levels of 5 highly
connected genes in the Cluster 5 - ASPM, CDKN3, NEK2,
RACGAP1, and TOP2A using quantitative RT-PCR. Statistically
significant co-expressions patterns were confirmed in an indepen-
dent tissue set between ASPM, CDKN3, and TOP2A. Addition-
ally, we also reported a statistically significant (p,0.05) overex-
pression of TOP2A in HCC tissue compared to normal liver
samples. In an analysis of 247 tissue samples from HCC, ASPM
was overexpressed in 66% of them, showing an association with
vascular invasion, early recurrence and poor prognosis [58].
Similarly, overexpression of TOP2A was associated with advance
histological grading, vascular invasion, and an early age onset of
HCC [59], while CDKN3 was reported as part of a vascular
invasion signature in HCC [60] and has been implicated in other
malignancies including breast and prostate cancers [61]. These
findings confirm that functionally similar genes tend to co-express
across multiple phenotypic conditions. Thus, the Conserved-Net
may be further used to characterize biological roles of unknown
genes given the functional properties of their co-expressions.
Although we could not validate RACGAP1-TOP2A, NEK2-
TOP2A, and CDKN3-NEK2 co-expressions, we noted a
statistically significant up-regulation of NEK2 and RACGAP1 in
fibrotic/cirrhotic tissue (p=0.002 and p=0.046 respectively). A
possible reason for this expression pattern could be an early role of
these genes in tumor initiation. NEK2 and RACGAP1 have been
shown to be involved in oncogenic pathways and oncogene-
regulated processes such as BRCA1- and Wnt-dependent signaling
cascades [62,63,64,65], possibly implicating these pathways in the
development of HCC.
Overall, the five analyzed genes were expressed in different
stages of liver disease, suggesting that consideration of graph
topology as well as differential expression may improve detection
of putative biomarkers in vivo. However, data generated in this
study is a preliminary verification of the computational analysis
rather than an exhaustive biomarker study, and thus a larger,
prospective study is critical.
This report presents a phenotype-specific resource for the study
of HCC with diverse etiology and varying degrees of progression.
With the rapidly increasing availability of comprehensive ‘‘omics’’
datasets in the public domain, it is likely that analytical approaches
described here will be valuable aids to clinicians and researchers
aiming at the elucidation of both the general and specific
mechanisms of tumor formation. Furthermore, expansion or
modification of this methodology may improve sensitivity and
specificity of novel diagnostic and prognostic markers and
contribute to the identification of appropriate strategies for
personalized patient treatment.
Methods
Data Preparation
Three publicly available human HCC microarray datasets were
included in this study, individually referred to as the HCC Dataset,
HCV Dataset, and Progression Dataset (Table 1). These datasets
corresponded to 264 arrays [44,66,67]. In the HCC Dataset,
‘Normal Liver’ refers to 5 pools of non-tumorous liver tissue,
specifically alcoholic cirrhosis, alcoholic noncirrhotic liver, HBV
noncirrhotic liver, HCV cirrhosis, and HBV cirrhosis. In the HCV
Dataset, ‘Normal Liver’ refers to non-tumorous liver tissue
obtained from deceased donors. Finally, in the Progression
Dataset, ‘Normal Liver’ refers to tissue obtained from the healthy
livers of patients undergoing resection for hepatic hemangioma.
Additional datasets, breast [68] (n=86 arrays), colon [69]
(n=47 arrays), and prostate [70] (n=154 arrays), as well as normal
human tissue arrays [16] (n=158) were obtained to measure
phenotype specificity of HCC datasets (Table 1). For all datasets
raw expression values were downloaded from the ArrayExpress
database [71] and normalized using Robust Multi-array Average
(RMA) [72]. To standardize annotation across microarray
platforms, Affymetrix probe identifiers were mapped to their
corresponding Ensembl gene identifiers [73]. Furthermore, to
facilitate integration of multiple public datasets, in cases where
multiple probesets mapped to a single gene, median intensity
values were retained. In this manuscript, networks from datasets
TABM-36, E-GEOD-14323, E-GEOD-6764, E-GEOD-15852,
E-MTAB-57, E-GEOD-17951, and E-TABM-145 were referred
to as HCC-Net, HCV-Net, Progression-Net, Breast-Net, Colon-
Net, Prostate-Net, and Normal-Net, respectively.
Gene network inference
Pairwise similarity in gene expression vectors was expressed by
the Pearson correlation coefficient (PCC). Gene pairs that
correlated above a predefined PCC threshold were represented
in the form of an undirected unweighted network, where nodes
correspond to genes and links (edges) correspond to co-expression
between genes. To infer the PCC threshold in an unbiased
manner, a systematic procedure was used based on the topological
difference between real and random co-expression networks [18].
This method is especially useful for integration of multiple
microarray studies performed on different platforms.
To confirm non-random behavior of real microarray networks,
we compared them to the Maslov-Sneppen (MS) model [23]. All
MS networks were generated by rewiring edges in the original
networks while preserving the degrees of the respective nodes. The
number of rewiring steps taken for each model was 46(number of
edges).
Graph analysis
Topological properties examined were node degree, between-
ness centrality, clustering coefficient, assortativity, diameter, and
modularity [74]. Node degree is defined as the total number of
edges that connect to a given node. Betweenness centrality is the
measure of node importance within a graph. Previously,
betweenness centrality was proposed as an indicator of biological
significance of a gene [27]. Clustering coefficient is the probability
that a node’s neighbors are interconnected. Assortativity is the
quantity that measures the tendency for nodes with similar
magnitude of degrees to be connected by an edge. Network
diameter is defined as the largest shortest path between any pair of
nodes in the network. Modularity is the strength of community
structure in graphs [75]. Network analyses were carried out using
the Functional Genomic Assistant (FUGA) toolbox [76]. Statistical
significance of differential topology was assessed using the
Wilcoxon rank sum test. P-values,0.05 were considered signifi-
cant.
Network partitioning and assessment of functional
similarity
Clusters of genes in a co-expression network were identified by
using either the Louvain method, a fast algorithm for community
detection in graphs using optimization of modularity [77] or the
Markov Cluster Algorithm (MCL), a fast and scalable algorithm
based on simulation of stochastic flow in graphs [78].
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to the same graph partition was measured by the Jaccard similarity
coefficient of overlapping Gene Ontology (GO) Biological Process
(BP), GO Cellular Component (CC), and Reactome pathways
terms. To ensure specificity of annotation within a gene cluster,
functional categories containing ,5o r.50 genes were removed.
For each co-expressed gene pair, the Jaccard coefficient was
expressed as the ratio of the number of common functional terms
to the number of total functional terms.
Functional enrichment
For a cluster with n genes and an a priori defined functional
category with K genes, the hypergeometric test was used to
evaluate the significance of the overlap k between the cluster and a
Gene Ontology term [79]. All genes in a network were used as
reference. Additionally, we used the Database for Annotation,
Visualization and Integrated Discovery (DAVID) [80] for
statistical enrichment of GO-Fat terms. Given the hierarchical
structure of the GO database, GO-Fat terms are manually curated
by the DAVID database and attempt to filter the broadest terms so
that they do not overshadow the more specific terms.
Extraction of total RNA and quantitative Real-time
Polymerase Chain Reaction (RT-PCR)
The study was approved by the Official Ethics Committee of the
Medical Faculty of the Otto-von-Guericke University of Magde-
burg and written informed consent to participate in the study was
obtained from all subjects included. Liver tissue was obtained by
ultrasound-guided fine-needle biopsy from eight patients with
HCC (lesional tissue), nine patients with Hepatitis C induced liver
fibrosis and from eight patients with elevated transaminases but
without underlying liver disease or structural changes of the tissue
architecture. Biopsies were snap frozen in liquid nitrogen upon
extraction and consequently transferred onto a 1.5 ml RNase-free
Eppendorf tube and submerged in 0.5 ml of TRIZOL-reagent
and stored at 280uC until processing.
Total RNA was extracted using a ‘‘two-step’’ protocol as
described previously [25]. Briefly, a single biopsy was homoge-
nized in 500 ml Trizol using disposable probes with tissue raptor
(QIAGEN, Hilden, Germany) on ice. After complete homogeni-
zation 200 ml chloroform was added, the sample was extensively
vortexed and centrifuged in a microcentrifuge (140006g, 4uC) for
15 min. The supernatant mixed with equal volume of isopropanol
in a new tube, vortexed and incubated on ice for 10 min.
Precipitated RNA was obtained by centrifugation (140006g, 4uC,
10 min), and resolved in 100 ml RNase-free water. Subsequently,
the RNA was purified using the RNeasy kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instruction. Finally, the
RNA was eluted in 70 ml RNase-free water. Aliquots of 5 ml each
were used for determination of RNA concentration via UV-
spectroscopy and to evaluate RNA integrity by agarose gel
electrophoresis. In each case, 500 ng of total RNA was transcribed
into cDNA in a 40 ml reaction volume by AMV reverse
transcriptase (Promega, Mannheim, Germany) and random
hexanucleotides (Boehringer, Mannheim, Germany) using stan-
dard protocol as described earlier [81].
Quantitative RT-PCR was performed in an iCycler (BioRad,
Munich, Germany). The 30 ml reaction mixture contained 10 ml
RNase-free water, 15 ml HotStarTaq-Sybr. Green, 0.2 ml of both
primers (50 mM) and 1.2 ml c-DNA. Initial denaturation and
activation of Taq-polymerase at 95uC for 15 min was followed by
40 cycles. The fluorescence intensity of the double-strand specific
SYBR-Green I, reflecting the amount of actually formed PCR-
product, was read real-time at the end of each elongation step.
Transcript amounts were calculated based on the Ct values of each
sample. Arbitrary units reflect the expression of the given gene in
relation to b-actin transcript amount. Primers used and the size of
expected PCR fragments are listed in Table 5.
Statistical analysis
RT-PCR data was analyzed using SPSS 12.0 (SPSS Inc., Chicago,
IL, USA) and graphs were generated using GraphPad Prism 4.0
(GraphPad Software Inc., San Diego, CA, USA). Non-parametric
testswere usedforstatisticalanalysesoftranscriptexpressionvaluesin
order to account for possibly skewed distributions. First, the Kruskal-
Wallis test was applied to each gene across all groups. In case of a
positive test result, the Mann-Whitney U test was performed to carry
out pairwise group comparisons. All test were two-tailed with a
significance level of p,0.05. Pearson correlation coefficient p-values
for transcript co-expressions were calculated using MATLAB’s
corrcoef function (2009a, The MathWorks, Natick, MA). Statistical
significance of gene network topologies was calculated using
Wilcoxon rank sum test and MATLAB implementation of the
ranksum function in the Statistics toolbox.
Supporting Information
Figure S1 Selection of Pearson correlation coefficient
threshold for gene co-expression network inference.
Clustering coefficients of real (black) and random (blue) networks
with identical node degree distributions were systematically
measured for 0.50#PCC#1.0. Threshold was selected at the first
local maximum of the difference (red) between the real and
random clustering coefficients.
(TIFF)
Figure S2 Selection of Pearson correlation coefficient
threshold for gene co-expression networks of HCC
microarrays without normal liver. Clustering coefficients
of real (black) and random (blue) networks with identical node
degree distributions were systematically measured for
0.50#PCC#1.0. Threshold was selected at the first local
maximum of the difference (red) between the real and random
clustering coefficients.
(TIFF)
Table S1 Gene co-expression network in Hepatocellular
Carcinoma.
(XLS)
Table 5. Primers used for quantitative RT-PCR analysis.
ASPM-a AACCCATTATCGCTGTGGCAC (21)
ASPM-b ACCACCAAGTGAAGCCCTGTTC (22)
CDKN3-a TCACCCATCATCATCCAATCGC (22)
CDKN3-b CTCGCAGGCTGTCTATGGCTTG (22)
NEK2-a CATTGGGCTGCTTGCTGTATG (21)
NEK2-b TTCTGGCTCTCCTAATTGTCGC (22)
RACGAP1-a TCTCAACAGAGGCCAACCATCC (22)
RACGAP1-b ACTGCAGAGCCAATGGAACGAG (22)
TOP2A-a TTTCAGGCCTTGGTGTGGTTGG (22)
TOP2A-b TCGCAGAAGAGAGGGCCAGTTG (22)
ß-actin-a CATGCCATCCTGCGTCTGGACC (22)
ß-actin-b ACATGGTGGTGCCGCCAGACAG (22)
doi:10.1371/journal.pone.0035510.t005
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sensus Hepatocellular Carcinoma network.
(XLS)
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